We develop cutting-edge technologies for bio big data mining and accelerating drug development through intelligent automation and AI innovation.

Q-omics is our AI-powered smart platform for effortless discovery, combining meta-databases, large language models (LLMs), Bio-LDM™, and machine learning to transform “text-to-data mining” into actionable insights for drug, target, and biomarker discovery.

At its core, OmixMind?an advanced AI agent within Q-omics?acts like a digital scientist, enabling natural language to research workflow conversion, automated data mining, and AI-driven result interpretation. Its evolving capabilities include hypothesis generation, contextual knowledge synthesis, and precision medicine discovery.

With Q-omics and OmixMind, CBIS transforms bioinformatics from a manual, iterative process into an autonomous, AI-driven discovery engine.

Bio-intelligence beyond LMMs: AI platform for autonomous interpretation of biological data and drug discovery